Arkolith/Insider Trading/IDYA/Form 4

Hata Yujiro S

President and CEO, DirectorIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Jan 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 16, 2024Option exercise(M)63K$4.31$270K741K
Jan 16, 2024Sell(S)63K$40.17$2.5M678K
Jan 12, 2024Sell(S)12K$40.04$491K678K
Jan 12, 2024Option exercise(M)12K$4.31$53K690K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 16, 2024Option exercise(M)63K—$0324K
Jan 12, 2024Option exercise(M)12K—$0387K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000028) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML